Food Dye Makes See-Through Mice
Duchenne approval exposes FDA rift over Sarepta gene therapy
CAR-T Cell Therapies Linked to Secondary Tumors
This company specializes in creating biomaterials for medical applications using silk
2024 SBIR/STTR Fall Conference
Foreign Threat Actors Bulletin
BCG’s second annual report on new drug modalities
FDA approves novel drug for the treatment of schizophrenia in adults
The Corporate Transparency Act (CTA)